HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Proteinuria >0.5 g/d, a prevalent prognostic factor for patient and graft survival in kidney transplantation.

AbstractUNLABELLED:
Proteinuria >0.5 g/d (HP) and serum creatinine (Scr) >120 micromol/L (HSC) at three months, two and five yr were compared as prognostic factors in kidney transplantation. We retrospectively analyzed 454 first transplants (follow-up: 100 +/- 3.2 months). Donor/recipient age, sex, panel reactive antibody (PRA), HLA mismatches, cold ischemia time, delayed graft function, acute rejection, blood pressure and its treatment, diabetes and anti-calcineurin use were also evaluated. Cox proportional hazard regression with time-dependent covariates to control for potentially confounding factors was used to analyze survival. The Kaplan-Meier product-limit estimate for survival according to urine protein excretion (< or = or >0.5 g/d) or Scr (< or = or >120 micromol/L) along with the log-rank test for all comparisons were computed. Statistical significance was set with p-value < 0.05.
RESULTS:
HSC is a prognostic factor of graft survival (HR: 2.54; 95% CI: 1.98-3.10; p < 0.01) only at five yr, but it does not predict mortality at any period. HP at three months (HR: 2.07; 95% CI: 1.70-2.43; p < 0.001) and at two yr 3.03 (2.54-3.51; p < 0.001) significantly predicts graft failure. HP at two yr is the prevailingly prognostic factor of patient survival in kidney transplantation (HR: 3.30; 95% CI: 1.94-5.62; p < 0.0001).
AuthorsFélix Cantarovich, Frank Martinez, Ricardo Heguilen, Eric Thervet, Marie-France Mamzer-Bruneel, Claudio Gonzalez, Christophe Legendre
JournalClinical transplantation (Clin Transplant) 2010 Mar-Apr Vol. 24 Issue 2 Pg. 175-80 ISSN: 1399-0012 [Electronic] Denmark
PMID19624694 (Publication Type: Journal Article)
Chemical References
  • Creatinine
Topics
  • Adult
  • Creatinine (blood)
  • Female
  • Graft Survival (physiology)
  • Humans
  • Kaplan-Meier Estimate
  • Kidney Transplantation (mortality, physiology)
  • Male
  • Multivariate Analysis
  • Prognosis
  • Proteinuria
  • Retrospective Studies
  • Risk Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: